UK markets closed

Arc Actions Biotech (FR0010734376.PA)

YHD - YHD Delayed price. Currency in EUR
Add to watchlist
401.13-21.24 (-5.03%)
At close: 06:07PM EDT

Arc Actions Biotech

260, Rue Guillaume du Vair

Management information
Xavier d'Ornellas,Lead manager since 3 December 1998
Morningstar style box
Yahoo partners with Morningstar, a leading market research and investment data group to help investors rate and compare funds on Yahoo Finance. The Morningstar Category is shown next to the Morningstar Style Box, which identifies a fund's investment focus, based on the underlying securities in the fund.
http://us.i1.yimg.com/us.yimg.com/i/fi/3_0stylelargeeq3.gif
Morningstar category
While the investment objective stated in a fund's prospectus may or may not reflect how the fund actually invests, the Morningstar category is assigned based on the underlying securities in each portfolio. Morningstar categories help investors and investment professionals make meaningful comparisons between funds. The categories make it easier to build well-diversified portfolios, assess potential risk and identify top-performing funds. We place funds in a given category based on their portfolio statistics and compositions over the past three years. If the fund is new and has no portfolio history, we estimate where it will fall before giving it a more permanent category assignment. Where necessary, we may change a category assignment based on recent changes to the portfolio.

Fund overview

CategorySector Equity Other
Fund familyFinancière de l'Arc
Net assets9.2M
YTD return-18.75%
Yield0.00%
Morningstar rating★★
Inception date17 May 2005

Fund operations

Last dividendN/A
Last cap gainN/A
Holdings turnover201.82%
Average for categoryN/A

Fees and expenses

ExpenseFR0010734376.PACategory average
Annual report expense ratio (net)4.76%0.00%
Prospectus net expense ratio0.00%N/A
Prospectus gross expense ratio0.00%N/A
Max 12b1 feeN/AN/A
Max front end sales load3.00%N/A
Max deferred sales load3.00%N/A
3-yr expense projection0N/A
5-yr expense projection0N/A
10-yr expense projection0N/A